Kyle Clagg is an experienced chemist with a comprehensive background in pharmaceutical chemistry, specifically in process development and synthesis. At Genentech, Kyle served as Scientist III, overseeing the discovery and evaluation of synthetic methods to ensure safe access to active pharmaceutical ingredients. Previous roles included Scientist II, where responsibilities encompassed early and late-stage process development, asymmetric catalysis, and project management. Kyle's early career included positions as Associate Scientist in both Process Chemistry and Medicinal Chemistry, focusing on route scouting and drug discovery. Educationally, Kyle holds a Bachelor of Arts in Biochemistry from the University of California, Berkeley, where undergraduate research was conducted on scalable synthesis methodologies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices